|
Home | Medical-Newswire.Com:
|
(Medical-NewsWire.com, August 27, 2016 ) Cilostazol develops fast after entering China, annual sales rising from CNY 35.95 million in 2010 to CNY 66.91 million in 2014 and CAGR during this period reaching 16.80%. Cilostazol enjoys a vast demand in China. Otsuka Co., Ltd, Zhejiang Weikang Pharmaceutical Co., Ltd, Chengdu Leer Pharmaceutical Co., Ltd, Pharsin and Yantai Yisheng Pharmaceutical Co., Ltd occupy the majority of the Chinese market, among which Otsuka Co., Ltd had the largest market share of about 63.62% with sales value reaching up to CNY 42.57 million in 2014.
Request sample at : https://marketreportscenter.com/request-sample/133472
Readers can get at least the following information through this report:
-market size of cilostazol in China
-competitive landscape of cilostazol market in China
-price of cilostazol made by different enterprises in China
-market outlook of cilostazol in China
Check for Discount at : https://marketreportscenter.com/request-discount/133472
The author suggests the following groups of people purchase this report:
-investors/research institutions interested in Chinese medicine market
--any interest in Chinese medicine market, please contact CRI for customized survey service
Browse full report with TOC : https://marketreportscenter.com/reports/133472/investigation-report-on-china-cilostazol-market-2010-2019
Connect for more details:
Sam Collins
Market Reports Center
Call us : 1-646-883-3044 (US)
Email : info@marketreportscenter.com
visit our website : https://marketreportscenter.com
Market Reports Center
Sam Collins
1-646-883-3044
sam@marketreportscenter.com
Source: EmailWire.Com 
Source: EmailWire.com
|
|
|
|
